Question 1

What is the catalog number for INO5042?

Accepted Answer

The catalog number for INO5042 is orb1709410.

Question 2

What sizes are available for INO5042?

Accepted Answer

INO5042 is available in the following size(s): 2 mg, 25 mg, 50 mg, 100 mg.

Question 3

How many pack sizes does INO5042 come in?

Accepted Answer

INO5042 is available in 4 different pack sizes.

Question 4

Is INO5042 in stock?

Accepted Answer

INO5042 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is INO5042 used for?

Accepted Answer

INO5042

Question 6

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

Question 7

How many freeze-thaw cycles can this product tolerate?

Accepted Answer

We recommend aliquoting the product upon receipt to avoid repeated freeze-thaw cycles, which can reduce activity and stability. This is your responsibility once the product has been delivered.

Question 8

Is antigen retrieval required for IHC with this antibody?

Accepted Answer

Recommended antigen retrieval methods, where applicable, are listed on the datasheet under the IHC protocol section.

INO5042

Product Specifications

CAS Number

Smiles

Molecular Formula

Molecular Weight

Storage Conditions

Notes

Available Sizes

Frequently Asked Questions

Explore Other Products

CCT6B (T-complex Protein 1 Subunit zeta-2, TCP-1-zeta-2, CCT-zeta-2, CCT-zeta-like, TCP-1-zeta-like, Testis-specific Tcp20, Testis-specific Protein TSA303) (MaxLight 550)

Human Protein-arginine deiminase type-6 (PADI6) ELISA Kit

Human Protein-arginine deiminase type-6 (PADI6) ELISA Kit

FGF21 Rabbit Polyclonal Antibody

DIMT1 Rabbit Polyclonal Antibody (PE)

BCAS2 (Breast Carcinoma Amplified Sequence 2, DAM1, Pre-mRNA-splicing factor SPF27, SPF27, Snt309) discontinued